Nariman K. Badr El-Din

639 citations
25 papers · 514 indexed · h-index 15
Topics
Cell death mechanisms and regulation (5 papers)Cancer Treatment and Pharmacology (4 papers)Cancer-related Molecular Pathways (4 papers)

In The Last Decade

Nariman K. Badr El-Din

24 papers receiving 496 citations

Peers

Nariman K. Badr El-Din
Comparison fields: 5 of 89
  • Molecular Biology 182
  • Plant Science 110
  • Biotechnology 64
  • Biochemistry 63
  • Oncology 60
Replace Norazalina Saad with:
Norazalina Saad Malaysia
Sen Lian South Korea
June‐Ki Kim South Korea
Yoo Sun Kim South Korea
Maryam Hamzeloo‐Moghadam Iran
Nurul Husna Shafie Malaysia
Casimiro Cárdenas Spain
Javier A. Garcia‐Vilas Spain
Anna Lichota Poland
Da Hye Kwon South Korea
Nariman K. Badr El-Din relative to Norazalina Saad Malaysia Norazalina Saad's profile →
Citations per field
00.5×1.5×
Norazalina Saad · 1×
Citations per year

Countries citing papers authored by Nariman K. Badr El-Din

Since Specialization
Citations

This map shows the geographic impact of Nariman K. Badr El-Din's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nariman K. Badr El-Din with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nariman K. Badr El-Din more than expected).

Fields of papers citing papers by Nariman K. Badr El-Din

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nariman K. Badr El-Din. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nariman K. Badr El-Din. The network helps show where Nariman K. Badr El-Din may publish in the future.

Co-authorship network of co-authors of Nariman K. Badr El-Din

This figure shows the co-authorship network connecting the top 25 collaborators of Nariman K. Badr El-Din. A scholar is included among the top collaborators of Nariman K. Badr El-Din based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nariman K. Badr El-Din. Nariman K. Badr El-Din is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 4
3 24
4 23
5 22
6 1
7 4
8 20
9 14
10 2
11
Modified arabinoxylan from rice bran, MGN-3/biobran, sensitizes metastatic breast cancer cells to paclitaxel in vitro.
35
12 20
13 35
14 15
15 0
16 55
17 88
18 11
19 31
20 19

About Nariman K. Badr El-Din

Nariman K. Badr El-Din is a scholar working on Biochemistry, Biotechnology and Toxicology, having authored 25 papers that have together received 514 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (5 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Biochemistry (63 citations), Biotechnology (64 citations) and Aquatic Science (35 citations). Nariman K. Badr El-Din has collaborated with scholars based in Egypt, United States and Saudi Arabia. Frequent co-authors include Mamdooh Ghoneum, Eman Noaman, Doaa A. Ali, Lorna Tolentino, Deyu Pan, Stanley T. Omaye, Sameh M. Shabana, Amina E. Essawy, Samuel W. French and Ashraf M. Abdel‐Moneim. Their work appears in journals such as Cancer Research, European Journal of Cancer and Cancer Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026